Written by Klarity Editorial Team
Published: Jul 10, 2026

Last updated: July 10, 2026
Anxiety disorders affect more than 40 million adults in the United States, yet navigating insurance coverage for anxiety treatment can feel overwhelming. If you have a BlueCross BlueShield of Mississippi (BCBS MS) health plan, this guide explains how the insurer’s internal be RxSmart pharmacy program typically handles anxiety medications, what prior authorization requirements may apply, how Mississippi parity law protects you, and how Klarity Health’s licensed providers may be able to help you access care.
Coverage varies by individual plan. Always verify your specific benefits with BCBS MS before scheduling an appointment.
BlueCross BlueShield of Mississippi is an independent licensee of the Blue Cross and Blue Shield Association. Unlike many BCBS affiliates in other states, BCBS MS operates its own internal pharmacy program called be RxSmart, with a Mississippi-licensed Pharmacy and Therapeutics (P&T) Committee that conducts quarterly formulary reviews. Industry claims routing data classifies BCBS MS as “Non Prime,” meaning it does not route through Prime Therapeutics (the PBM used by most other BCBS affiliates).
This guide focuses on commercial PPO and ACA Marketplace plans using the be RxSmart formulary. FEP and state employee members should consult their separate plan documents.
BCBS MS organizes covered medications into four cost categories under the be RxSmart program:
Generic First (Step Therapy) Policy: be RxSmart applies a Generic First policy across most drug classes. This means BCBS MS typically requires members to try and fail a lower-cost generic equivalent before authorizing coverage of a brand-name medication. For anxiety treatment, this most commonly affects brand-name SSRIs and SNRIs — nearly all first-line anxiety medications have low-cost generic alternatives available, so step therapy is unlikely to delay initial treatment for most patients.
The following tables reflect how BCBS MS’s be RxSmart formulary may typically handle anxiety medications as of mid-2026. Tier placements and PA requirements are subject to quarterly P&T Committee review — verify current tier status via the be RxSmart drug search at bcbsms.com or by calling member services at 800-942-0278.
All SSRIs are non-scheduled (no DEA controlled substance designation). No EPCS requirement applies.
| Medication | Generic Name | be RxSmart Category | Prior Auth? | Notes |
|---|---|---|---|---|
| Sertraline (Zoloft generic) | Sertraline HCl | Category 1 | No | Most commonly prescribed SSRI for anxiety; very low cost-share |
| Escitalopram (Lexapro generic) | Escitalopram oxalate | Category 1 | No | Widely used for GAD and social anxiety; preferred formulary position |
| Fluoxetine (Prozac generic) | Fluoxetine HCl | Category 1 | No | Approved for panic disorder and OCD; long half-life reduces missed-dose sensitivity |
| Paroxetine (Paxil generic) | Paroxetine HCl | Category 1–2 | No | FDA-approved for GAD, panic, social anxiety, PTSD; generic widely available |
| Citalopram (Celexa generic) | Citalopram HBr | Category 1 | No | Off-label use for panic and anxiety; preferred as generic |
| Lexapro (brand) | Escitalopram | Category 3 | Step therapy | Brand requires prior generic escitalopram trial under Generic First policy |
All SNRIs are non-scheduled. No EPCS requirement applies.
| Medication | Generic Name | be RxSmart Category | Prior Auth? | Notes |
|---|---|---|---|---|
| Venlafaxine ER (Effexor XR generic) | Venlafaxine HCl ER | Category 1–2 | No | FDA-approved for GAD, social anxiety, and panic disorder; taper required on discontinuation |
| Duloxetine (Cymbalta generic) | Duloxetine HCl | Category 1–2 | No | FDA-approved for GAD; also covers comorbid pain conditions |
| Desvenlafaxine (Pristiq generic) | Desvenlafaxine succinate | Category 2–3 | Step therapy | May require venlafaxine ER trial first under step therapy protocol |
Buspirone and hydroxyzine are non-scheduled with no abuse potential. No EPCS requirement applies.
| Medication | Generic Name | be RxSmart Category | Prior Auth? | Notes |
|---|---|---|---|---|
| Buspirone (Buspar generic) | Buspirone HCl | Category 1 | No | Non-habit-forming; preferred for long-term GAD management; no sedation, no dependence risk |
| Hydroxyzine (Vistaril/Atarax generic) | Hydroxyzine HCl / Pamoate | Category 1 | No | Non-controlled antihistamine anxiolytic; useful for situational anxiety and PRN dosing |
Benzodiazepines are DEA Schedule IV controlled substances — a lower classification than Schedule II. Mississippi’s EPCS statute (Miss. Code Ann. § 41-29-137) applies only to Schedule II substances. Benzodiazepines are entirely exempt from EPCS requirements — they may be prescribed electronically or on paper at the provider’s discretion.
| Medication | Generic Name | be RxSmart Category | Prior Auth? | Notes |
|---|---|---|---|---|
| Alprazolam (Xanax generic) | Alprazolam | Category 2 | Quantity limits | Schedule IV; quantity limits apply; short-term/PRN use; generic widely covered |
| Clonazepam (Klonopin generic) | Clonazepam | Category 2 | Quantity limits | Schedule IV; longer half-life than alprazolam; FDA-approved for panic disorder |
| Lorazepam (Ativan generic) | Lorazepam | Category 2 | Quantity limits | Schedule IV; intermediate half-life; common for situational/procedural anxiety |
| Diazepam (Valium generic) | Diazepam | Category 2 | Quantity limits | Schedule IV; long half-life; less commonly prescribed for primary anxiety management |
Benzo quantity limits: be RxSmart typically applies quantity limits to benzodiazepines (e.g., a 30-day supply cap, or daily dosage limits). Long-term use beyond 90 days may require a prior authorization review. Your BCBS MS plan documents will specify exact quantity limit parameters.
Most first-line generic anxiety medications (SSRIs, SNRIs at Category 1–2, buspirone, hydroxyzine) do not require prior authorization under be RxSmart. PA is most likely to be required in these scenarios:
Mississippi’s Electronic Prescribing for Controlled Substances (EPCS) statute — Miss. Code Ann. § 41-29-137 — mandates electronic prescribing only for Schedule II controlled substances. No anxiety medication used by Klarity providers is a Schedule II drug.
This means Klarity’s telehealth providers face no EPCS-related barrier when prescribing anxiety medications to Mississippi BCBS MS members. Initial consultations, prescription refills, and follow-up care can all occur via telehealth without the prescribing workflow limitations that apply to Schedule II medications (such as ADHD stimulants).
Mississippi’s Mental Health Parity and Insurance Reform Act — Miss. Code Ann. § 83-9-353 et seq. — requires that health insurance policies regulated by the Mississippi Insurance Department provide mental health and substance use disorder benefits on terms no more restrictive than comparable medical-surgical benefits. Anxiety disorders are recognized mental health conditions covered under this parity mandate.
Practically, this means BCBS MS may not:
The federal Mental Health Parity and Addiction Equity Act (MHPAEA) — reinforced by the 2024 MHPAEA final rule — adds a second layer of parity protection for employer-sponsored group health plans. MHPAEA prohibits group health plans from applying quantitative or non-quantitative treatment limitations to mental health benefits that are more restrictive than those applied to medical-surgical benefits in the same classification.
Mississippi state parity law applies to fully-insured health insurance policies regulated by the MS Insurance Department. If your employer is self-funded (self-insured), your plan is governed by ERISA federal law rather than Mississippi state statutes. Self-funded plans are not subject to Miss. Code Ann. § 83-9-353, but they remain subject to MHPAEA. Check your Summary Plan Description (SPD) to determine whether your plan is fully-insured or self-funded.
Klarity Health does not currently accept Mississippi Medicaid (Division of Medicaid / MS DOM). This guide applies to BCBS MS commercial, ACA Marketplace, and FEP members only. Mississippi Medicaid members should contact the MS Division of Medicaid at 1-800-421-2408 or visit medicaid.ms.gov to identify participating mental health providers.
If your BCBS MS claim or prior authorization for anxiety medication or treatment is denied, you have the right to appeal. The standard appeals pathway for BCBS MS fully-insured commercial plans is:
Many BCBS MS commercial plans include telehealth coverage for mental health services, including psychiatric evaluation and medication management for anxiety disorders. However, telehealth benefits vary by specific plan. Check your Summary of Benefits and Coverage (SBC) or call 800-942-0278 to confirm telehealth mental health coverage on your plan.
BCBS MS PPO plans generally do not require a referral to see a mental health specialist. HMO-style plans may require a referral from your primary care physician. Review your plan type and consult your member ID card or member portal to confirm whether a referral is needed before your appointment.
Most first-line anxiety medications are not controlled substances. SSRIs (sertraline, escitalopram, fluoxetine), SNRIs (venlafaxine, duloxetine), buspirone, and hydroxyzine have no DEA scheduling and are not controlled substances. Benzodiazepines (alprazolam, clonazepam, lorazepam) are DEA Schedule IV — a low-risk controlled substance classification with appropriate monitoring but none of the prescribing restrictions associated with Schedule II drugs like ADHD stimulants.
No. Mississippi’s EPCS requirement (Miss. Code Ann. § 41-29-137) applies only to Schedule II controlled substances. No anxiety medication — including benzodiazepines (Schedule IV) — is a Schedule II drug. Your Klarity provider can prescribe anxiety medications through standard telehealth workflows without any EPCS-specific requirements.
BCBS MS’s be RxSmart Generic First policy requires trying a generic medication before a brand-name equivalent. For anxiety treatment, this is rarely a barrier: nearly every first-line anxiety medication — sertraline, escitalopram, fluoxetine, venlafaxine ER, duloxetine, buspirone — is available as a low-cost generic at Category 1. Step therapy is most likely to affect brand-name requests (e.g., Lexapro brand when the generic escitalopram is equally effective). If you have a clinical reason to use a specific brand, your provider can submit documentation supporting a step therapy exception.
Quantity limits on benzodiazepines reflect clinical guidelines recommending short-term or as-needed (PRN) use due to the potential for dependence with long-term daily dosing. These limits are applied consistently across commercial plans and are not specific to BCBS MS. For patients with a clinical need for ongoing benzo use (e.g., panic disorder with frequent breakthrough episodes), your provider can submit a prior authorization with supporting documentation to request a quantity limit exception.
Submit a written internal appeal to BCBS MS with supporting documentation from your provider. If denied, request an External Independent Review through the Mississippi Insurance Department’s IRO process. If you suspect a parity violation, file a complaint with the MS Insurance Department (1-800-562-2957) or the DOL (1-866-444-3272) for ERISA self-funded plans.
No. Klarity Health is not affiliated with, endorsed by, or in any way connected to BlueCross BlueShield of Mississippi, the Blue Cross and Blue Shield Association, or any BCBS subsidiary or licensee. This guide is provided as independent educational information to help patients understand their insurance benefits. Coverage determinations are made solely by BCBS MS according to your specific plan terms.
Disclaimer: This page is for informational purposes only and does not constitute insurance, legal, or medical advice. Coverage determinations are made by BlueCross BlueShield of Mississippi based on your individual plan terms. Always verify your benefits before scheduling care. Klarity Health is not affiliated with BlueCross BlueShield of Mississippi, the Blue Cross and Blue Shield Association, or any BCBS entity.
Find the right provider for your needs — select your state to find expert care near you.